Reviva Pharmaceuticals I...

AI Score

XX

Unlock

0.56
-0.06 (-9.79%)
At close: Apr 02, 2025, 3:59 PM
0.59
4.82%
After-hours: Apr 02, 2025, 04:34 PM EDT

Reviva Pharmaceuticals Statistics

Share Statistics

Reviva Pharmaceuticals has 46.58M shares outstanding. The number of shares has increased by 56.22% in one year.

Shares Outstanding 46.58M
Shares Change (YoY) 56.22%
Shares Change (QoQ) 0%
Owned by Institutions (%) 22.87%
Shares Floating 41.63M
Failed to Deliver (FTD) Shares 1.48K
FTD / Avg. Volume 0.1%

Short Selling Information

The latest short interest is 5.3M, so 11.37% of the outstanding shares have been sold short.

Short Interest 5.3M
Short % of Shares Out 11.37%
Short % of Float 12.72%
Short Ratio (days to cover) 19.04

Valuation Ratios

The PE ratio is 0 and the forward PE ratio is -2.19. Reviva Pharmaceuticals's PEG ratio is 0.

PE Ratio 0
Forward PE -2.19
PS Ratio 0
Forward PS 0.2
PB Ratio 21.43
P/FCF Ratio -4.33
PEG Ratio 0
Financial Ratio History

Enterprise Valuation

Currently the Enterprise Value (EV) is not available for Reviva Pharmaceuticals.

EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 1.38, with a Debt / Equity ratio of 0.

Current Ratio 1.38
Quick Ratio 1.38
Debt / Equity 0
Debt / EBITDA 0
Debt / FCF 0
Interest Coverage 0

Financial Efficiency

Return on Equity is n/a and Return on Invested Capital is n/a.

Return on Equity n/a
Return on Assets n/a
Return on Invested Capital n/a
Revenue Per Employee $0
Profits Per Employee $-2,617.4B
Employee Count 15
Asset Turnover 0
Inventory Turnover n/a

Taxes

Income Tax -16.95B
Effective Tax Rate 43188.89%

Stock Price Statistics

The stock price has increased by -82.13% in the last 52 weeks. The beta is -0.1, so Reviva Pharmaceuticals's price volatility has been lower than the market average.

Beta -0.1
52-Week Price Change -82.13%
50-Day Moving Average 1.49
200-Day Moving Average 1.35
Relative Strength Index (RSI) 19.59
Average Volume (20 Days) 1.47M

Income Statement

Revenue n/a
Gross Profit 0
Operating Income -39,503.6B
Net Income -39,260.8B
EBITDA -39,503.6B
EBIT -39.24M
Earnings Per Share (EPS) -1.65
Full Income Statement

Balance Sheet

The company has 23.37M in cash and 0 in debt, giving a net cash position of 23.37M.

Cash & Cash Equivalents 23.37M
Total Debt 0
Net Cash 23.37M
Retained Earnings -134.35M
Total Assets 7.63M
Working Capital -10.72M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -28.32M and capital expenditures 0, giving a free cash flow of -28.32M.

Operating Cash Flow -28.32M
Capital Expenditures 0
Free Cash Flow -28.32M
FCF Per Share -1.19
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

RVPH does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Payout Ratio n/a
Earnings Yield n/a
FCF Yield n/a
Dividend Details

Analyst Forecast

The average price target for RVPH is $9.5, which is 1432.3% higher than the current price. The consensus rating is "Buy".

Price Target $9.5
Price Target Difference 1432.3%
Analyst Consensus Buy
Analyst Count 6
Stock Forecasts

Scores

Altman Z-Score -40.99
Piotroski F-Score 1